医学
安慰剂
碱性磷酸酶
随机化
临床终点
置信区间
内科学
胆红素
胃肠病学
熊去氧胆酸
随机对照试验
病理
酶
生物
生物化学
替代医学
作者
Gideon M. Hirschfield,Christopher L. Bowlus,Marlyn J. Mayo,Andreas E. Kremer,John M. Vierling,Kris V. Kowdley,Cynthia Levy,Alejandra Villamil,A. Cetina,Ewa Janczewska,Ehud Zigmond,Jeong Heo,Yusuf Yılmaz,Yiannis Kallis,Christophe Corpechot,Peter Buggisch,Pietro Invernizzi,Maria Carlota Londoño Hurtado,Sandrin C. Bergheanu,Ke Yang,Yun‐Jung Choi,Daria B. Crittenden,Charles A. McWherter
标识
DOI:10.1056/nejmoa2312100
摘要
Effective treatments for patients with primary biliary cholangitis are limited. Seladelpar, a peroxisome proliferator-activated receptor delta agonist, has potential benefits.
科研通智能强力驱动
Strongly Powered by AbleSci AI